Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Replimune (REPL) Liabilities and Shareholders Equity (2018 - 2025)

Replimune has reported Liabilities and Shareholders Equity over the past 8 years, most recently at $333.6 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $333.6 million for Q4 2025, down 44.74% from a year ago — trailing twelve months through Dec 2025 was $1.7 billion (down 17.92% YoY), and the annual figure for FY2025 was $551.3 million, up 13.04%.
  • Liabilities and Shareholders Equity reached $333.6 million in Q4 2025 per REPL's latest filing, down from $389.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $678.6 million in Q4 2022 and bottomed at $333.6 million in Q4 2025.
  • Median Liabilities and Shareholders Equity over the past 5 years was $513.6 million (2021), compared with a mean of $515.3 million.
  • The largest annual shift saw Liabilities and Shareholders Equity skyrocketed 132.0% in 2021 before it tumbled 44.74% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $485.3 million in 2021, then surged by 39.83% to $678.6 million in 2022, then fell by 21.46% to $532.9 million in 2023, then rose by 13.27% to $603.6 million in 2024, then plummeted by 44.74% to $333.6 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for REPL at $333.6 million in Q4 2025, $389.4 million in Q3 2025, and $469.5 million in Q2 2025.